Floatz logo

162 assets in Mantle Cell Lymphoma

Therapeutic assets addressing Mantle Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Lisaftoclax
Mantle Cell Lymphoma
Ruijin HospitalP2CCC (53)
Navitoclax
Mantle Cell Lymphoma
Peter MacCallum Cancer Centre, AustraliaP2CCC (53)
Polatuzumab
Mantle Cell Lymphoma
Medical University of ViennaP2CCC (53)
Tafasitamab
Mantle Cell Lymphoma
Paolo Caimi, MDP2CCC (53)
Ublituximab
Mantle Cell Lymphoma
Yazeed SawalhaP2/3CCC (53)
Zamtocabtagene Autoleucel
Mantle Cell Lymphoma
Miltenyi Biomedicine GmbHP2CCC (53)
Cart-19 Cells
Mantle Cell Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3CCC (52)
Diphenhydramine
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2CCC (52)
Fludeoxyglucose
Mantle Cell Lymphoma
Alliance for Clinical Trials in OncologyP3CCC (52)
Loncastuximab Tesirine
Mantle Cell Lymphoma
University of WashingtonP2CCC (52)
Nemtabrutinib
Mantle Cell Lymphoma
Vanderbilt-Ingram Cancer CenterP2CCC (52)
Palbociclib
Mantle Cell Lymphoma
Alliance Foundation Trials, LLC.P2CCC (52)
Tocilizumab
Mantle Cell Lymphoma
Australasian Leukaemia and Lymphoma GroupP2CCC (52)
Zilovertamab Vedotin
Mantle Cell Lymphoma
Merck Sharp & Dohme LLCP2CCC (52)
Thiotepa
Mantle Cell Lymphoma
Fred Hutchinson Cancer CenterP2CCC (51)
Ari-0001
Mantle Cell Lymphoma
GUSTAVO SALGUEROP1/2CCC (50)
Eprenetapopt
Mantle Cell Lymphoma
M.D. Anderson Cancer CenterP2CCC (50)
Parsaclisib
Mantle Cell Lymphoma
Incyte CorporationP3CCC (49)
[18F]F-RESCA-R8B4
Mantle Cell Lymphoma
RenJi HospitalP2CCC (48)
[18F]F-RESCA-RCCB6
Mantle Cell Lymphoma
RenJi HospitalP2CCC (48)
[18F]F-RESCA-RD06
Mantle Cell Lymphoma
RenJi HospitalP2CCC (48)
[68ga]ga-nota-r8b4
Mantle Cell Lymphoma
RenJi HospitalP2CCC (48)
[68ga]ga-nota-rd06
Mantle Cell Lymphoma
RenJi HospitalP2CCC (48)
CD47/SIRPA-BLOCKING AGENT ALX148
Mantle Cell Lymphoma
M.D. Anderson Cancer CenterP1/2CCC (48)
Iopofosine (¹³¹I)
Mantle Cell Lymphoma
Cellectar Biosciences, Inc.P2CCC (48)
Lentivirus Vector Ccr5 Shrna
Mantle Cell Lymphoma
AIDS Malignancy ConsortiumP1/2CCC (48)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Mantle Cell Lymphoma
AIDS Malignancy ConsortiumP1/2CCC (48)
Linperlisib
Mantle Cell Lymphoma
Dalian Medical UniversityP2CCC (48)
mb-106
Mantle Cell Lymphoma
Mustang BioP1/2CCC (48)
Mgta-456
Mantle Cell Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (48)
Pacritinib
Mantle Cell Lymphoma
City of Hope Medical CenterP2CCC (48)
R-Dhaox
Mantle Cell Lymphoma
Sun Yat-sen UniversityP2CCC (48)
Surovatamig
Mantle Cell Lymphoma
AstraZenecaP1/2CCC (48)
Treosulfan
Mantle Cell Lymphoma
Fred Hutchinson Cancer CenterP2CCC (48)
Umbralisib
Mantle Cell Lymphoma
Yazeed SawalhaP2/3CCC (48)
Aleta-001
Mantle Cell Lymphoma
Cancer Research UKP1/2CC (47)
Baff-R Car-T
Mantle Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1/2CC (47)
cd22 car-transduced t cells
Mantle Cell Lymphoma
Essen BiotechP1/2CC (47)
Epcoritamab
Mantle Cell Lymphoma
GenmabP1/2CC (47)
Golcadomide
Mantle Cell Lymphoma
City of Hope Medical CenterP1/2CC (47)
IM19 CAR-T cells
Mantle Cell Lymphoma
Beijing Immunochina Medical Science & Technology Co., Ltd.P1/2CC (47)
Interferon ?1 (Human Fibroblast Protein Moiety)
Mantle Cell Lymphoma
Fred Hutchinson Cancer CenterP1/2CC (47)
Plerixafor
Mantle Cell Lymphoma
Case Comprehensive Cancer CenterP1/2CC (47)
cd19-ucart
Mantle Cell Lymphoma
University of Colorado, DenverP1/2CC (46)
Lacutoclax
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P1/2CC (45)
Pemigatinib
Mantle Cell Lymphoma
University of UtahP2CC (45)
prt2527
Mantle Cell Lymphoma
Prelude TherapeuticsP1CC (44)
Tazemetostat
Mantle Cell Lymphoma
Weill Medical College of Cornell UniversityP1CC (44)
Adi-001
Mantle Cell Lymphoma
Adicet TherapeuticsP1CC (43)
Autologous Baffr-Targeting Car T Cells
Mantle Cell Lymphoma
Mayo ClinicP1CC (43)
Showing 51 to 100 of 162 assets
PreviousPage 2 of 4Next